FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice
Steatosis
Lipogenesis
Sphingolipid
Sphingomyelin phosphodiesterase
Ceramide synthase
DOI:
10.1194/jlr.m093799
Publication Date:
2019-05-20T19:29:02Z
AUTHORS (8)
ABSTRACT
Nonalcoholic fatty liver disease (NAFLD), a leading cause of dysfunction, is metabolic that begins with steatosis. Sphingolipid metabolites, particularly ceramide and sphingosine-1-phosphate (S1P), have recently received attention for their potential roles in insulin resistance hepatic FTY720/fingolimod, prodrug the treatment multiple sclerosis, phosphorylated vivo to its active form by sphingosine kinase 2 has been shown interfere actions S1P inhibit biosynthesis. Therefore, this study we investigated effects FTY720 diet-induced animal model NAFLD (DIAMOND) recapitulates hallmarks human disease. The oral administration these mice fed high-fat diet sugar water improved glucose tolerance reduced In addition decreasing triglycerides, also sphingolipid levels, including ceramides, monohexosylceramides, sphingomyelins, C16:0 C24:1 species, as well dihydro-S1P. decreased acid synthase (FASN) expression DIAMOND without affecting other key enzymes lipogenesis. had no effect on SREBP-1c, which transcriptionally activates FASN. However, agreement notion an inhibitor histone deacetylases, FTY720-P accumulated liver, H3K9 acetylation was markedly increased mice. Hence, might be useful attenuating FASN triglyceride accumulation associated Erratum: FTY720/fingolimod decreases steatosis nonalcoholic miceJournal Lipid ResearchVol. 61Issue 2PreviewVOL 60 (2019) PAGES 1311–1322 Full-Text PDF Open Access (NAFLD) encompasses spectrum states defined occurring absence alcohol abuse (1Satapathy S.K. Sanyal A.J. Epidemiology natural history disease.Semin. Liver Dis. 2015; 35: 221-235Crossref PubMed Scopus (246) Google Scholar). Steatosis initial stage NAFLD, lipid droplets accumulate (2Cohen J.C. Horton J.D. Hobbs H.H. Human disease: old questions new insights.Science. 2011; 332: 1519-1523Crossref (1566) This can self-limiting; however, progress more aggressive injury, inflammation, fibrosis steatohepatitis (NASH) (3Farrell G.C. Larter C.Z. from cirrhosis.Hepatology. 2006; 43: S99-S112Crossref (1961) NASH cirrhosis, end-stage disease, or hepatocellular carcinoma (4Farrell van Rooyen D. Gan L. Chitturi S. inflammatory disorder: pathogenic, prognostic therapeutic implications.Gut Liver. 2012; 6: 149-171Crossref (299) Caloric excess, obesity, resistance, dyslipidemia, implicated development (5Rinella M.E. Management NAFLD: stage-based approach.Nat. Rev. Gastroenterol. Hepatol. 2016; 13: 196-205Crossref (214) Scholar), it estimated about third US population (6Loomba R. global epidemic.Nat. 2013; 10: 686-690Crossref (1186) Approximately 30% 50% patients at time diagnosis (7Williams C.D. Stengel J. Asike M.I. Torres D.M. Shaw Contreras M. Landt C.L. Harrison S.A. Prevalence among largely middle-aged utilizing ultrasound biopsy: prospective study.Gastroenterology. 140: 124-131Abstract Full Text (1576) Scholar) and, unfortunately, there are currently approved therapies (8Sanyal Friedman S.L. McCullough Dimick-Santos Challenges opportunities drug biomarker steatohepatitis: findings recommendations American Association Study Diseases-U.S. Food Drug Administration Joint Workshop.Hepatology. 61: 1392-1405Crossref (251) oversupply nutrients due obesogenic consumption alters many aspects cellular metabolism, biosynthesis lipids (9Chavez J.A. Summers oversupply, selective lipotoxicity: molecular mechanisms.Biochim. Biophys. Acta. 2010; 1801: 252-265Crossref (131) Several mediators typically lipotoxicity, such diacylglycerols, free acids, oxysterols, recently, sphingolipids, linked progression Scholar, 10Gorden D.L. Myers D.S. Ivanova P.T. Fahy E. Maurya M.R. Gupta Min Spann N.J. McDonald J.G. Kelly et al.Biomarkers progression: lipidomics approach epidemic.J. Res. 56: 722-736Abstract (206) 11Luukkonen P.K. Zhou Y. Sadevirta Leivonen Arola Oresic Hyotylainen T. Yki-Jarvinen H. Hepatic ceramides dissociate non-alcoholic disease.J. 64: 1167-1175Abstract (262) It suggested bioactive contributes enhanced involved (12Chavez A ceramide-centric view resistance.Cell Metab. 15: 585-594Abstract (430) 13Pagadala Kasumov Zein N.N. Kirwan J.P. Role disease.Trends Endocrinol. 23: 365-371Abstract (215) 14Rohrbach Maceyka Spiegel Sphingosine pathobiology.Crit. Biochem. Mol. Biol. 2017; 52: 543-553Crossref (45) 15Choi Snider Sphingolipids high fat obesity-related diseases.Mediators Inflamm. 2015: 520618Crossref (75) genetic pharmacological inhibition mouse models obesity (16Holland W.L. Bikman B.T. Wang L.P. Yuguang G. Sargent K.M. Bulchand Knotts T.A. Shui Clegg D.J. Wenk al.Lipid-induced mediated proinflammatory receptor TLR4 requires saturated acid-induced mice.J. Clin. Invest. 121: 1858-1870Crossref (490) 17Meikle P.J. phospholipids related disorders.Nat. 79-91Crossref (236) 18Turpin S.M. Nicholls H.T. Willmes Mourier A. Brodesser Wunderlich C.M. Mauer Xu Hammerschmidt P. Bronneke H.S. al.Obesity-induced CerS6-dependent production promotes weight gain intolerance.Cell 2014; 20: 678-686Abstract (423) 19Raichur S.T. Chan P.W. Li Ching Chaurasia B. Dogra Ohman M.K. Takeda K. Sugii al.CerS2 haploinsufficiency inhibits beta-oxidation confers susceptibility 20 ([Erratum. 2014. Cell Metab., 919. ]): 687-695Abstract (304) 20Gosejacob Jager P.S. Vom Dorp Frejno Carstensen A.C. Kohnke Degen Dormann Hoch Ceramide 5 essential maintain C16:0-ceramide pools obesity.J. Chem. 291: 6989-7003Abstract (84) manipulation (CerS) isoforms 2, 5, 6 suggests composed long side chains, C16:0, play important role obesity-induced intolerance, steatohepatitis, adipose tissue inflammation (18Turpin Furthermore, positive association between containing chains independent triglycerides reported humans (11Luukkonen 21Bergman B.C. Brozinick J.T. Strauss Bacon Kerege Bui Sanders Siddall Wei Thomas al.Muscle sphingolipids during rest exercise: C18:0 signature humans.Diabetologia. 59: 785-798Crossref (88) Levels metabolite (S1P) produced two isoenzymes, SphK1 SphK2, were elevated livers (HFD) (22Fayyaz Henkel Japtok Kramer Damm Seehofer Puschel G.P. Kleuser Involvement 1-phosphate palmitate-induced hepatocytes via S1P2 subtype.Diabetologia. 57: 373-382Crossref (63) Moreover, SphK1/S1P axis mediate induced high-saturated-fat feeding (23Geng Sutter Harland M.D. Law B.A. Ross J.S. Lewin Palanisamy Russo S.B. Chavin K.D. Cowart L.A. mediates initiates signaling hepatocytes.J. 2359-2371Abstract (54) suggesting levels circulation may some systemic HFD (15Choi increases plasma obese correlated fasting level, body percentage, mass index (24Kowalski G.M. Carey A.L. Selathurai Kingwell Bruce C.R. Plasma obesity.PLoS One. 8: e72449Crossref (117) To improve understanding provide insights into future avenues, studied (25Jacobs Warda A.S. Verbeek Cassiman Spincemaille An overview past present.Curr. Protoc. Mouse 185-200Crossref (29) most do not exhibit full features physiological, metabolic, histologic, transcriptomic, cell-signaling changes seen progressive developed (26Asgharpour Cazanave S.C. Pacana Seneshaw Vincent Banini Kumar D.P. Daita H.K. Mirshahi F. al.A cancer.J. 65: 579-588Abstract (270) preclinical developing better diagnostic strategies NASH, targeting those early-stage advanced (27Sanyal lipidomic readout disease.Trans. Am. Climatol. Assoc. 126: 271-288PubMed understand involvement metabolites used orally available immunosuppressive treating sclerosis (28Brinkmann V. Billich Baumruker Heining Schmouder Francis Aradhye Burtin Fingolimod (FTY720): discovery treat sclerosis.Nat. Discov. 9: 883-897Crossref (958) CerS vitro (29Lahiri Park Laviad E.L. Lu X. Bittman Futerman A.H. synthesis modulated analog mixture uncompetitive noncompetitive Acyl-CoA chain length-dependent manner.J. 2009; 284: 16090-16098Abstract (105) 30Berdyshev E.V. Gorshkova I. Skobeleva Dudek Mirzapoiazova Garcia Natarajan synthases up-regulates dihydrosphingosine formation lung endothelial cells.J. 5467-5477Abstract (136) de novo cultured cells (30Berdyshev 31Chen Tran Eckerd Huynh T.P. Elliott M.H. Brush R.S. Mandal N.A. Inhibition protects rat retina light-induced degeneration.J. 54: 1616-1629Abstract (39) (32Stiles Qi Sun Tan Porter Allegood Chalfant C.E. Yasumura Matthes M.T. LaVail M.M. al.Sphingolipid profile retinal dystrophic P23H-1 rats delay 818-831Abstract (27) 33Oyeniran C. Sturgill J.L. Hait N.C. Huang W.C. Avni Newton Montpetit Conrad D.H. al.Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) dysregulates homeostasis exacerbates allergic asthma Allergy Immunol. 136: 1035-1046.e6Abstract addition, reduces (34Lim K.G. Tonelli Z. Pyne analogues 1 inhibitors: enzyme kinetics, allosterism, proteasomal degradation, actin rearrangment MCF-7 breast cancer 286: 18633-18640Abstract (109) 35Liang Nagahashi Kim E.Y. Harikumar K.B. Yamada Price al.Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal colitis-associated cancer.Cancer Cell. 107-120Abstract (435) Our results suggest could beneficial early development. Isogenic derived C57BL/6J 129S1/SvImJ backgrounds (B6/129) kindly provided Dr. Sandra Erickson (UCSF) maintained inbreeding previously described housed under 12-h light/12-h dark cycle 21–23°C facility. All procedures Animal Care Use Committee Virginia Commonwealth University. Genome-wide mapping revealed striking differences control female male (36Norheim Hui Kulahcioglu Mehrabian Cantor R.M. Pan Parks B.W. Lusis Genetic hormonal 58: 178-187Abstract (34) Female because severity HFD-induced precludes interrogation pathogenesis sex-independent manner. standard chow (CD; Harlan TD.7012) until reaching 12 weeks age unless indicated otherwise. Mice then high-fat, high-carbohydrate (Harlan TD.88137) 42% kcal milk 0.1% cholesterol (Western diet; WD) 16 weeks. Drinking contained amount fructose (23.1 g/l) (18.9 (sugar water; SW) Both food ad libitum. (0.3 mg/kg; Cayman Chemical #10006292) vehicle (saline) administered gavage three times week throughout 16-week HFD. Where indicated, CD normal drinking water. weighed euthanized inhaled isoflurane cervical dislocation. Livers removed, portion sectioned formalin fixation histological processing. remaining placed cryotubes snap-frozen liquid nitrogen. Formalin-fixed paraffin-embedded slices stained H&E. examined staining Masson's trichrome Sirus Red (37Lattouf Younes Lutomski Naaman N. Godeau Senni Changotade Picrosirius red staining: tool appraise collagen networks pathological tissues.J. Histochem. Cytochem. 62: 751-758Crossref (294) expert pathologist evaluated histology treatment-blinded NASH-Clinical Research Network scoring system score steatosis, lobular ballooning 38Kleiner D.E. Brunt E.M. Van Natta Behling Contos M.J. Cummings O.W. Ferrell L.D. Liu Y.C. Torbenson M.S. Unalp-Arida A.M. al.Design validation disease.Hepatology. 2005; 41: 1313-1321Crossref (7112) (percentage droplets) scored 0 (<0.5%), (5–33%), (>33–66%) (>66%). Hepatocyte (none), (few cells), (many cells). Lobular (no foci), (<2 foci per field), (2–4 (>4 foci). Steatosis, scores combined activity score. Fibrosis F0 F1 (mild), F2 (perisinusoidal portal/periportal fibrosis), F3 (bridging F4 (obvious cirrhosis). fasted overnight, baseline blood measured tail-vein blood. Glucose (1 mg dextrose/kg weight) dissolved sterile PBS injected intraperitoneally. Blood determined 15, 30, 60, 90, 120 min postglucose injection. measurements Accu-Chek Compact plus glucometer (Roche Diagnostics), areas curve (39Andrikopoulos Blair A.R. Deluca Fam Proietto Evaluating test mice.Am. Physiol. 2008; 295: E1323-E1332Crossref (535) Repeat tests performed after several days. For test, intraperitoneally (0.75 U/kg weight), prior 30 tissues pulverized nitrogen lysed buffer 50 mM HEPES, pH 7.4, 150 NaCl, 100 NaF, 10% glycerol, 10 sodium pyrophosphate, 200 μM vanadate, EDTA, 1% Triton X-100 supplemented Halt Protease Phosphatase Inhibitor Cocktail (#78446, Thermo Fisher Scientific). Proteins separated SDS-PAGE transferred nitrocellulose membranes (Immun-Blot, #1620115; Bio-Rad). Membranes blocked 5% BSA-TBST incubated overnight (#3189); β-actin (Cell Signaling) (#4967). Immunopositive bands visualized incubation HRP-conjugated secondary antibodies (1:5000 dilution; Jackson ImmunoResearch) h room temperature before adding SuperSignal West Pico chemiluminescence substrate (#34080, Blots quantified ImageJ normalized corresponding loading controls. homogenized 7.8, KCl, 0.1 Na3VO4, DTT, phosphatase protease cocktail (Thermo Scientific) ice 15 min. NP-40 added final concentration 0.75% (v/v), suspension vortexed s 4 Nuclear cytoplasmic fractions centrifugation 3,000 g 4°C. Nuclei resuspended high-salt 0.4 M 1:500 inhibitors, sonicated ice, extracts cleared SDS-PAGE, transblotted nitrocellulose, primary figure legends, rabbit polyclonal H3-K9ac (1:1000; AbCam) H3 Signaling). RNA extracted TRIzol Reagent (15596-018, Ambion, (2 µg) treated RQ1 DNase (M6101, Promega) converted High-Capacity cDNA Reverse Transcription Kit (4368814, cDNA. SYBR Green PCR Master Mix mixed Bio-Rad primers gapdh (CED0027497) fasn (CID0015083). Reactions analyzed use CFX Connect Real-Time Detection System (Bio-Rad) (40Hait Strub Singh Luo Marmorstein Kordula Milstien al.Regulation nucleus sphingosine-1-phosphate.Science. 325: 1254-1257Crossref (745) Gene calculated ΔΔCt method GAPDH expression. collected veins, serum obtained 1,500 Serum alanine aminotransferase, aspartate cholesterol, HDL, LDL, University Hospital Department Pathology. Lipids whole blood, LC/ESI/MS/MS (AB Sciex 5500) (41Cai Oyeniran Biwas D.D. ORMDL proteins regulate inflammation.J. 1412-1422Abstract (30) Statistical significance unpaired two-tailed Student's t-tests comparisons groups ANOVA followed post hoc (GraphPad Prism). P < 0.05 indicate statistical significance. Previous studies demonstrated B6/129 SW mimics typical WD (42Charlton Krishnan Viker Sanderson McConico Masuoko Gores Fast mouse: novel small ballooning, fibrosis, physiological fidelity condition.Am. Gastrointest. 301: G825-G834Crossref (272) triggers agreement, observed when calories together (SW) they rapidly gained (Fig. 1A), 1B) 1C) compared CD. Similar previous showed higher following intraperitoneal SW, although statistically significant 1D). As expected, li
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (80)
CITATIONS (44)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....